Sort
48,018 grants matching “immunotherapy”
Isolation and Distribution of high quality human pancreatic islets
$693,572Ali Naji · University Of Pennsylvania · U42 · FY2007 · RR
Mapping infant and adult T cell immunity
$693,465Brian David Rudd · Cornell University · R37 · FY2025 · AI
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC
$693,401Sana D Karam · Washington University · R01 · FY2025 · CA
Clinical Trials using TCR Transduced T Cells for Adoptive Immunotherapy
$693,336David J Cole · Loyola University Chicago · P01 · FY2012 · CA
Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases
$693,184Ouri Cohen · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$693,152Irving Lerner Weissman · Stanford University · R35 · FY2017 · CA
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$692,707Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · CA
Optimizing immunoradiotherapy for HNSCC
$692,235Joseph A Califano · University Of California, San Diego · R01 · FY2023 · CA
Personalized Adoptive T-cell Therapy for AML
$692,077David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Montefiore Einstein Clinical Oncology Training Program in the Bronx
$691,824Amit Verma · Albert Einstein College Of Medicine · K12 · FY2025 · CA
Poxvirus
$691,663Stuart N. Isaacs · University Of Maryland Baltimore · U54 · FY2008 · AI
Development of small near-infrared laser system capable of improving immune responses to vaccines (laser-based adjuvant)
$691,508David Bean · Veralase, Llc · R42 · FY2017 · AI
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis
$691,469Daniel Hill Zimmerman · Cel-Sci Corporation · R44 · FY2018 · AR
Base editing approaches to enable an HIV cure
$691,427Saar Gill · University Of Pennsylvania · P01 · FY2025 · AI
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$691,384John H Sampson · Duke University · P01 · FY2020 · CA
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
$691,271Fei Chen · Broad Institute, Inc. · R01 · FY2023 · CA
Prostate Cancer Immunotherapy
$691,169Robert B Darnell · Rockefeller University · R01 · FY2007 · CA
Adoptive Cellular Therapies to Enhance Tolerance and Protective Immunity
$691,150Leslie S Kean · Emory University · U19 · FY2010 · AI
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$690,978Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES
$690,960Massimo T Pietropaolo · Baylor College Of Medicine · R01 · FY2020 · DK
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations
$690,941Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · HG
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal
$690,909Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2024 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$690,908Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
$690,864Evan Michael Graboyes · Medical University Of South Carolina · R01 · FY2025 · CA
Combinatorial application of nanoscale technologies to target a novel mechanism of immune evasion by cancer cells
$690,825Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2025 · CA